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Abstract 
Background: A third of the world population is infected with tuberculosis (TB) bacilli. TB accounts for 25 % of all 
avoidable deaths in developing countries. The objective of the study was to assess impact of directly observed treat-
ment short-course (DOTS) strategy on new tuberculosis case finding and treatment outcomes in Somali Regional 
State, Ethiopia from 2003 up to 2012 and from 2004 up to 2013, respectively.
Methods: A health facility based retrospective study was employed. Quarterly reports were collected using World 
Health Organization (WHO) reporting format for TB case finding and treatment outcome from all zones in the region 
to the Federal Ministry of Health.
Results: A total of 31, 198 all types of new TB cases were registered and reported during the period from 2003 up 
to 2012, in the region. Out of these, smear positive pulmonary TB cases were 12,466 (40 %), and 10,537 (33.8 %) and 
8195 (26.2 %) for smear negative pulmonary TB and extra-pulmonary TB cases, respectively. An average case detection 
rate (CDR) of 19.1 % (SD 3.6) and treatment success rate (TSR) of 85.5 % (SD 5.0) for smear positive pulmonary TB were 
reported for the specified years period. For the overall study period, trend chi-squire analysis for CDR was X2 = 2.1; 
P > 0.05 and X2 = 5.64; P < 0.05 for TSR.
Conclusions: The recommended TSR set by WHO was achieved (85.5 %) and the CDR reported was far below 
(19.1 %) from the recommended target. Extensive efforts should be established to maintain the achieved TSR and 
to increase the low CDR for the smear positive pulmonary TB cases through implementing alternative case finding 
strategies.
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Background
According to the World Health Organization (WHO) 
Global tuberculosis (TB) report 2012, there were an esti-
mated 8.7 million incident cases and 12 million prevalent 
cases of TB globally, in 2011, of which 1.1 million (13 %) 
were among people living with human immunodeficiency 
virus (HIV) [1]. Although the number of TB cases was 
stable or falling in 5 of 6 WHO regions, it is growing in 
Africa where the TB epidemic is still driven by the spread 
of HIV [2]. The HIV pandemic presents a massive chal-
lenge to global TB control with a co-infection prevalence 
rate of 5 % or more in 8 African countries [3].
According to WHO global TB report in 2012, which 
considered the findings from the national TB prevalence 
survey, there were an estimated 220,000 (258 cases per 
100,000 populations) incident cases of TB in Ethiopia in 
2011. The same report mentioned that the prevalence of 
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TB was estimated to be 200,000 (237 cases per 100,000 
populations). Additionally, there were an estimated 
15,000 deaths (18 cases per 100,000 populations) due to 
TB, excluding HIV related deaths in the country during 
the same period [4].
Directly observed treatment short-courses (DOTS) 
are both practical and effective for diagnosis, treatment, 
and monitoring of TB. Each of the five components of 
DOTS—political and administrative commitment; case 
detection, primarily by microscopic examination of spu-
tum of patients presenting to health facilities; stand-
ardized short course chemotherapy given under direct 
observation; adequate supply of good quality drugs; 
and systematic monitoring and accountability for every 
patient diagnosed—is integral to success [5].
On the other hand, some studies didn’t detect the advan-
tage of DOTS over self-administered treatment [6, 7]. In 
other studies, defaulting and poor methods of diagnosis, 
treatment and monitoring of treatment [8] were observed.
In Ethiopia, DOTS, which was fully implemented in the 
country in 2000, its coverage was 70 and 95 % in 2003 and 
2004, respectively. Similarly, 90 % of the country’s popu-
lation had true access to DOTS because of low health 
coverage [9]. Case detection rate in Ethiopia was 36 % in 
2004 whereas treatment success rate for new smear pos-
itive cases in the DOTS strategy was 80  % in 2000 and 
dropped to 70 % in 2003 [2] with no obvious explanation 
for deterioration.
Even though it is critical to evaluate the impact of the 
program in different parts of the country, few similar 
researches were conducted in some parts of the country in 
which the findings revealed that there were more gaps in 
organizational issues such as misuse and under use of TB 
registration books, challenges in follow-up of TB patients, 
low case detection of TB and increased rate of treatment 
defaulter [10]. A study which investigated a 10-year expe-
rience of TB control program in Southern region of Ethio-
pia has shown weaknesses in organizational issues such 
as under use of the TB registry, deficient follow-up pro-
cedures, and alarming rates of defaulting [10]. The same 
result of low case detection rate (CDR) and treatment suc-
cess rate (TSR) were also reported by Kidanemariam and 
Alemayehu [11, 12]. Similarly Woldeyohannes et  al. [13] 
and Sisay et  al. [14] reported low level of CDR in Addis 
Ababa and Gambela regions, respectively. Therefore, this 
study aimed at evaluating the impact of the DOTS pro-
gram on new TB case findings and their treatment out-
come in Somali Regional State, Ethiopia.
Methods
Study design
Institutional based retrospective data was collected for 
TB cases who were registered and reported from 2003 
up to 2012 and for their treatment outcome from 2004 to 
2013 in Somali Regional State.
Study area
According to the 2007 report from Central Statistical 
Agency (CSA) of Ethiopia, Somali Regional State had a 
total population of 4,445,219. Out of whom, males and 
females consisted of 2,472,490 (55.6  %) and 1,972,729 
(44.4  %), respectively. Urban populations were esti-
mated to be 623,004 (14.02 %), while 1,687,858 (37.97 %) 
were pastoralist populations. With an estimated area 
of 279,252 square kilometers, the regional state had an 
estimated density of 15.9 persons per square kilometer. 
For the entire regional state, 685,986 households were 
counted, which indicated that an average of 6.8 persons 
was residing in a single household. The average urban 
and rural household holding capacities were 6 and 6.5 
persons, respectively. The regional state is divided into 9 
administrative zones and 53 districts [15].
Source population
All new TB patients in the region.
Study population
New TB patients who were registered during the study 
period.
Inclusion and exclusion criteria
All forms of TB cases registered during the study period 
were included in the study. Treatment outcome of smear-
positive pulmonary tuberculosis cases were focused 
and evaluated as smear-positive TB cases are the main 
sources of infection for community. Treatment outcome 
of extra-pulmonary tuberculosis and smear-negative pul-
monary tuberculosis cases were excluded as data for their 
treatment outcome are not explicitly completed.
Data collection methods and procedures
WHO standardized reporting formats as instrument of 
data collection tools were used to collect the necessary 
data on case detection and treatment outcome. Data 
were first collected from health facilities (HF) where 
TB focal persons compiled the data from registration 
books, report and submit it on quarterly basis to zonal 
TB focal persons, and in turn, the zonal TB focal persons 
submit report to regional TB program officer who fre-
quently checked for completeness, quality and accuracy 
of reports. Finally, summarized, analyzed, interpreted 
and compiled data report were sent to the National 
Tuberculosis and Leprosy Control Program (NTLCP) of 
Federal Ministry of Health (FMoH) by regional TB pro-
gram officer. Trained data collectors and investigators 
collected data reported from all DOTS implementing 
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health facilities in all zones of the region. Data collectors 
were participated in collecting information from TB reg-
istration books in the facilities by using WHO reporting 
formats through cross-checking the reports which were 
made by TB focal persons for the purpose of assuring 
quality of data. Data collectors also collected summary 
data of all zonal reports to Regional Health Bureau by 
comparing data which were previously reported by zonal 
TB focal persons. Similarly, data were collected from the 
Regional Health Bureau by looking through the reports 
which were made by the regional TB focal person to the 
FMoH.
Data validation
Currently, FMoH is implementing Health Manage-
ment Information System (HMIS) for all health program 
including TB for recording and reporting purposes, 
which consisted of its own unique data collection book 
(registration book) and reporting format. Data which 
were obtained by WHO reporting formats for TB case 
detection and treatment for the study period were cross-
checked for the same information which was reported 
through HMIS for maintaining accuracy of the reporting 
data for the same study period.
Operational definitions
Case definition
Case detection rate: Percentage of smear-positive TB 
cases detected among the total number of TB cases esti-
mated to occur. Estimation was made by WHO estimat-
ing factor for each reporting year for the study period 
by considering the incidence rate of TB from the total of 
100,000 populations.
New case: A patient who has never had treatment for TB 
or has been on anti-TB treatment for less than 4 weeks.
Relapse: A patient who has been declared cured or 
treatment completed from any form of TB in the past but 
found to be smear-positive or culture positive.
Return after default: A patient who had previously been 
recorded as defaulted from treatment and returns to the 
health service with smear-positive sputum.
Treatment outcome
Treatment success rate: the sum of cure rate and comple-
tion rate.
Defaulter: A patient who has been on treatment for at 
least 4 weeks and whose treatment was interrupted for 8 
or more consecutive weeks.
Transfer out: A patient who has started treatment and 
has been transferred to another health facility and for 
whom treatment outcome is not known at the time of 
evaluation.
Cured: A patient who is sputum smear-negative one 
month prior to the completion of treatment and on at 
least one previous occasion (usually at the end of the 2nd 
or 5th month).
Treatment completed: A patient who has completed 
treatment but in whom smear result are not available at 
or one month prior to the completion of treatment.
Treatment failure: A patient who remained smear posi-
tive or became again smear positive at the end of five 
months or later after commencing treatment.
Died: A patient who dies for any reason during the 
course of treatment.
Treatment success rate: A sum of TB cases who com-
pleted treatment and who declared cured.
Data analysis
SPSS version 20.0 packages were used to analyze and 
interpret the data. We entered the variables in SPSS 
based on reporting years, case detection rate, treatment 
outcome (cured, death, failure, treatment success rate, 
relapse, and default etc.). Data were summarized using 
frequencies, percentages and standard deviations includ-
ing mean values. Trends of TB cases, CDR and TSR were 
analyzed using chi-squire for trends.
Ethical considerations
The study secured ethical approval from Somali Regional 
State Health Bureau Ethical Clearance Committee. Con-
sent was requested from Somali Regional State Health 
Bureau and FMoH in order to get the necessary second-
ary data of all DOTS implementing facilities in the zones 
of the region.
Results
A total of 31,198 all types of new TB cases were regis-
tered and reported from 2003 to 2012 in the study area. 
Out of these, smear-positive pulmonary TB cases were 
12,466 (40 %), and 10,537 (33.8 %) and 8195 (26.2 %) for 
smear-negative pulmonary TB and extra- pulmonary TB 
cases, respectively. The highest all new TB cases were 
registered in the year 2010 and lowest in the year 2009 
with a total number of 4543(14.5  %) and 1977(6.3  %), 
respectively (Table  1). There was a consistent increase 
trend in the number of all new TB cases from 2602 in the 
year 2005 to 4543 in 2010 (Trend X2 = 4.5; P < 0.05).
From the year 2006 up to 2012, a total number of 7737 
new smear positive pulmonary TB cases were registered. 
And out of these, 4678 (60  %) were males and the rest 
were females. The highest numbers [2436 (31.4  %)] of 
new smear positive TB cases were registered in the age 
group of 15–24 and followed by 2002 (26  %) in the age 
group of 25–34, while the least new smear positive TB 
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cases [41 (1 %)] were registered in the age group of 0–14 
(Table 2).
The average CDR for new smear positive pulmonary 
TB cases was found to be 19.1  % for the overall study 
period, on the other hand, the lowest CDR (12 %) and the 
highest CDR (23 %) were observed in the years of 2011 
and 2009; respectively (Fig.  1), with the overall study 
period Trend X2 = 2.1; P > 0.05.
A total number of 12,466 smear-positive pulmonary 
TB cases were registered for the study period. Of them, 
12,041(93.6  %) were evaluated for their treatment out-
comes from 2004 up to 2013 in the region. Among the 
total evaluated smear positive TB cases, an average cure 
rate of and TSR were found to be 81.9 and 85.5 %, respec-
tively. TSR (85.5 %) were calculated by adding cure rate 
(81.9  %) and treatment complete rate (3.6  %) for the 
overall study period. The lowest (73.1 %) and the highest 
(90.8 %) TSRs were observed in 2004 and 2011; respec-
tively, with the overall study period Trend X2  =  5.64; 
P < 0.05.
As far as death rate, treatment failure rate, defaulter 
and transfer out rates are concerned, they were found to 
be 4.5, 0.8, 4.2 and 4.0 % for the study period, respectively 
(Table  3). In the study period, the cure rate and treat-
ment success rate increased from 82.9 to 86.2 % and from 
84.4 to 90.2 %, respectively. The death rate and defaulter 
rate had increases from 2.9 to 5.4 % with average value of 
being 4.5 % (SD 1.1) and from 2.3 % up to 4.7 % with aver-
age value of being 4.2 % (SD 1.03) over the study period, 
respectively. Moreover, treatment failure rate and transfer 
out rate fluctuated over the study period with the average 
value of being 4.2 and 4.0 %, respectively (Table 3).
Discussion
The CDR for new smear positive pulmonary TB cases 
for the overall study period was found to be 19.1 %. The 
overall low CDR relative to the WHO target of 70  % 
might be as the result of CDR relies and calculated based 
on the estimated prevalence in the country as denomi-
nator and that estimated prevalence is high making the 
Table 1 All new TB case findings in Somalia Region from 2003 to 2012
Year Smear positive  
PTB (N)
% Smear negative  
PTB (N)
% Extra Pulmonary  
TB (N)
% All forms  
of TB (N)
2012 902 31.3 1141 39.7 835 29.0 2878
2011 769 39.0 753 38.0 455 23.0 1977
2010 1439 31.7 1850 40.7 1254 27.6 4543
2009 1495 34.8 1716 40.0 1083 25.2 4294
2008 1406 42.8 1037 31.6 838 25.6 3281
2007 1249 40.0 1121 35.7 761 24.3 3131
2006 1381 44.6 882 28.5 834 26.9 3097
2005 1166 44.8 677 26.0 759 29.2 2602
2004 1289 46.1 759 27.1 749 26.8 2797
2003 1370 52.8 601 23.1 627 24.1 2598
Total 12,466 40.0 10,537 33.8 8195 26.2 31,198
Table 2 Total number of smear positive new TB cases by sex and age group in Somalia Regional State from 2006 to 2012
Age Sex Total
Male Female No. %
No. % No. %
0–4 22 54 19 46 41 1
5–14 169 49 173 51 342 4
15–24 1481 61 955 49 2436 31.4
25–34 1213 61 789 49 2002 26
35–44 736 59 518 41 1254 16
45–54 507 61 321 59 828 11
55–54 312 62 190 48 502 7
65+ 238 74 94 36 332 4
Total 4678 60 3059 40 7737 100
Page 5 of 7Woldeyohannes et al. BMC Res Notes  (2015) 8:357 
CDR low. It is, therefore, difficult to measure accurately 
in most settings especially in the context of a high preva-
lence of HIV [16]. Other possible reasons might be due 
to inadequate decentralization of DOTS program, short-
age of resource and trained personnel and low sensitiv-
ity of smear microscopy. Likewise, researches carried out 
in different regions of Ethiopia reported different case 
detection rates. Low CDRs were reported in Oromia 
by Kidanemariam et  al. (31.7  %) [11], Alemayehu et  al. 
(23.7  %) in Benshangul [12] and Sisay et  al. (40.9  %) in 
Gambela region [14]. And, relatively higher CDR (68 %) 
was reported by Woldeyohannes et  al. in Addis Ababa, 
Ethiopia [13]. For Africa the CDR was reported to be 
63 % while that of the world for all forms of TB in 2012 
was reported to be 66  % [1]. The difference in reported 
CDR could be attributed to the calculation for CDR done 
based on WHO estimate, burden of HIV, different popu-
lation size between studies, and TB diagnostic capabili-
ties of the region etc.
An average value of TSR of 85.5  % was achieved for 
the overall study period, which was almost similar to 
that of WHO target and national average 84 % [17] and 
was higher than Africa 72  % [2]. In studies from differ-
ent parts of Ethiopia, a relatively lower TSRs of 80  % 
[13], 55.7 % [14], 81 % [11], 66.41 % [12], 80 % [18] and 
80.5 % [19] were reported. The high TSR reported in the 
study might therefore suggest good performance by the 
Region’s TB program in the areas of adherence and follow 
up of patients to the course of treatment, relatively proper 
recording and reporting system, adequate treatment regi-
mens and decrease in incidence of drug resistant strains, 
and government commitment to ensure comprehensive 
TB control activities [20]. In other similar studies which 
were carried out in Enugu and Ebonyi States in Nigeria 
reported TSR of 82 and 80 %, respectively [21, 22]. How-
ever, a relatively higher TSR (88.2 %) was reported from a 
five year retrospective study done in Mersin, Turkey [23]. 
In the current study, TSR for the years (2004–2013) var-
ied from 73.1 to 90.8  %. The reasons for the disparities 
should be explored by the Region TB program so as to 
improve the disease control.
The cure rate accepted as safer and more valuable 
indicator than treatment success rate [24] was approx-
imately 80  % in the world at large, 60  % in Europe and 
Turkey between 2005 and 2008, and has been noted to 
increase since [25] and 57.88  % in Mersin, Turkey [23] 
and (68.6 %) in one retrospective study (1997–2011) car-
ried out in Arsi Zone, Central Ethiopia [19]. In our study, 
it was observed that the cure rate is relatively higher than 
in Europe, Mursin/Turkey and Arsi Zone, Central Ethio-
pia and almost equal to in the world at large. In this study 
during the study period, the reduction in the death rate, 
treatment failure rate, default rate, and transfer out rate 
had significant effects on the increase of treatment suc-
cess and cure rate.
Treatment completion rate was reported to be 7  % in 
the world between 2005 and 2008 and remained con-






















Fig. 1 Trend of CDR and TSR in Somalia Region from 2003 to 2012
Table 3 Treatment outcome of smear positive pulmonary TB cases in Somalia region from 2004 to 2013








Death (%) Failure (%) Default (%) Transfer
out (%)
2013 769 769 86.2 4.0 90.2 2.9 0.6 2.3 4
2012 1439 1439 87.0 3.8 90.8 3.0 0.5 2.7 3.0
2011 1495 1304 85.0 4.0 89.0 3.1 0.5 3.5 4.1
2010 1406 1364 80.8 6.7 87.5 5.0 0.7 4.5 2.1
2009 1249 859 81.8 3.6 85.4 5.8 0.0 4.9 3.8
2008 1381 1307 78.2 6.3 84.5 4.7 1.2 4.7 4.7
2007 1166 1166 82.6 2.4 85.0 4.8 1.0 4.8 4.4
2006 1289 1166 82.6 2.4 85.0 4.8 1.3 4.5 4.4
2005 1370 1370 72.1 1.0 73.1 5.5 0.8 5.5 5.2
2004 1297 1297 82.9 1.5 84.4 5.4 1.1 4.7 4.3
Total 12,861 12,041 81.9 3.6 85.5 4.5 0.8 4.2 4.0
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44 % in Turkey, respectively [25] and 30.38 % in one ret-
rospective study (2004–2008) carried out in Mersin, Tur-
key [23] and 16.2  % in study carried out in Arsi Zone, 
Central Ethiopia. In our study, treatment completion 
rate in Somalia was relatively lower than the value in the 
world, Europe, Turkey and report from Arsi Zone, Cen-
tral Ethiopia. Again, in our study, while treatment com-
pletion rate increased during the 10-year period which is 
important in terms of indicating a reduction in the num-
ber of microbiological analyses rate at the beginning and 
end of therapy.
A 0.8 % of average treatment failure rate among smear 
positive pulmonary TB cases was reported. In other 
three similar studies done in different regions of Ethio-
pia, the same low treatment failure rates were reported 
[11, 13, 19]. In study carried out in Mersin, Turkey [23] 
reported a relatively higher average treatment failure rate 
of 4.26  %. The lower treatment failure rate in our study 
could be due to the overall low prevalence of multi drug 
resistant tuberculosis (MDR TB) in Ethiopia which was 
1.6 % at national level [26] and 1.1 % in Eastern Ethiopia 
[27] for new smear positive cases.
Secondary data from the Region’s TB program was 
used for the study; therefore, minimal errors could have 
occurred during data entry and computations but would 
not have affected the study’s results. In addition, DOTs 
coverage for each year of the study period was not avail-
able which prevents the study from addressing the signif-
icant of expansions of the program on the current CDR 
and TSR. Also, the periods of years reviewed for all study 
objectives were not uniform (from 2003 to 2006, for 
example, for new smear-positive pulmonary TB cases) 
because of incomplete data, which limited trend assess-
ments for such variable.
Conclusions
The recommended treatment success rate set by WHO 
was achieved (85.5  %) and the reported CDR was very 
low (19.1  %). Efforts should be there to maintain the 
achieved TSR and to increase low CDR for smear-posi-
tive pulmonary TB cases observed in the region.
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